Gregory Forlenza, MD
Disclosures: Other: Researcher, speaker, Advisory Board-Medtronic (Any division)|Other: Researcher, Speaker, Consultant-Insulet|Other: Researcher, Speaker, Consultant-Tandem|Other: Researcher, Speaker, Consultant-Dexcom|Other: Researcher, Consultant-Abbott (Any division)|Other: Researcher, Consultant-Beta Bionics|Other: Researcher, Consultant-Lilly (Any division) - 07/31/2023

Greg Forlenza Bio

 

Dr. Forlenza is an Associate Professor and pediatric endocrinologist at The Barbara Davis Center at the University of Colorado Anschutz Medical Campus. He has been caring for children with type 1 diabetes for over 15 years. He conducts research funded by the National Institutes of Health, the Juvenile Diabetes Research Foundation, the Helmsley Charitable Trust, and the National Science Foundation. His industry research has focused on the pediatric development and approval of the Medtronic 670G, 770G, 780G, Tandem Control-IQ, Insulet Omipod 5, Beta Bionics iLet, Dexcom G6 and G7, Medtronic Guardian 4, and Abbott Freestyle Libre 2. His research is focused on the use of technology to improve the health and lifestyle of people with type 1 diabetes.